Tom Brassington

Advising Revvity, Inc. on the sale of its applied, food and enterprise services businesses to New Mountain Capital

Advising PerkinElmer, Inc. on public takeover offers for each Horizon Discovery Group plc, Oxford Immunotec Global plc and Immunodiagnostic Systems Holdings plc 

Advising Novartis Institutes for Biomedical Research (NIBR) on its acquisition of Arctos Medical

Advising Sandoz AG on the acquisition of the worldwide product rights for Mycamine®, an antifungal agent, from Astellas Pharma Inc

Advising Smiths Group plc on the acquisitions of Seebach GmbH and United Flexible, Inc and its investment in Ivenix, Inc

Advising Google on a variety of corporate transactions in the UK

Advising The British Council on the sale of its IELTS business in India to IDP Education Limited

Advising The Anschutz Corporation in respect of the US$5.8bn acquisition of Regal Entertainment Group by Cineworld Group plc

Advising Recordati on its US$300m acquisition of the European commercial rights to AstraZeneca's blood pressure and heart failure products, Seloken, Seloken ZOK and Logimax

Advising McCormick & Co. on its takeover offer for Premier Foods plc

Advising News Corporation on various transactions including the acquisitions of Shine and Unruly

Advising Electra Private Equity PLC on the demerger of Hostmore plc onto the London Stock Exchange

Advising Lockheed Martin on various transactions, including the separation and combination of its IT and technical services businesses with Leidos

Advising Intrexon Corporation on the acquisition of Oxitec Ltd., a pioneer in biological insect control solutions

Advising Jazz Pharmaceuticals PLC on the sale of a portfolio of pharmaceutical products and medical devices to Essex Woodlands Fund IX L.P

Advising Kingfisher PLC on the sale of its controlling stake in B&Q China to Beijing-based Wumei Holdings

Advising Johnson and Johnson on transactions including acquisitions of Spectrum Vision; OTC brands of JB Chemicals & Pharmaceuticals Limited; and Finsbury Orthopaedics on business disposal

Advising Bestway Group on the acquisition of the Co-operative Group's Pharmacy business for £620m

Advising Aeroflex on its US$1.5bn sale to Cobham plc

Advising the trustees of the Kodak Pension Plan on the acquisition of the Personalized Imaging and Document Imaging businesses of Eastman Kodak

Advising Ares Capital on its participation in a debt-for-equity swap and placing, and then subsequent take private, of Healthcare Locums plc

Advising RBC Capital Markets as sponsor to Petra Diamonds Limited's admission to the Official List and to trading on the Main Market of the LSE

Advising Moor Park on the £700m sale and leaseback of 12 Spire Healthcare hospitals

Advising Numis Securities Limited in its capacity as nominated adviser and broker to Clinigen Group Plc on Clinigen's IPO and admission to AIM